Warwick Delprado
Papers
1
Total Citations
4
H-Index
1
About
Warwick Delprado is a leading urological pathologist whose work has significantly advanced the understanding and treatment of prostate cancer. His research centers on the histopathological characterization of prostate tumors, with a particular focus on the outcomes of focal therapies and salvage surgeries. Delprado’s major contributions include pioneering the pathological evaluation of irreversible electroporation (IRE) as a focal treatment for prostate cancer, demonstrating its feasibility and limitations. His 2021 study on salvage robot-assisted radical prostatectomy (sRARP) following IRE, which has garnered 4 citations, provides critical insights into the oncological and functional outcomes for patients with recurrent disease. This work has helped shape clinical decision-making for men who fail focal therapy. Beyond this, Delprado is recognized for his extensive expertise in prostate cancer grading and his role in refining pathological assessment protocols. His research, though niche, has had a tangible impact on urological oncology, offering a roadmap for managing complex cases. Delprado’s dedication to bridging pathology and surgical outcomes makes him a respected figure in the field, guiding both researchers and clinicians toward more personalized, effective prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1